JHVEPhoto
The U.S. Meals and Drug Administration (FDA) has accepted Sanofi’s (NASDAQ:SNY) meningococcal vaccine MenQuadfi for infants as younger as six weeks, increasing its earlier label indicated for youngsters aged two years and above.
The quadrivalent shot designed to guard in opposition to
